Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis f508del transgenic mice

Journal of Pediatric Gastroenterology and Nutrition

Volumn 47, Issue 5, 2008, Pages 547-554

  Ohlsson, Lena ^a,d   Hjelte, Lena ^b   Hühn, Michael ^b   Scholte, Bob J ^c   Wilke, Martina ^c   Flodström Tullberg, Malin ^b   Nilsson, Åke ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d BioMedical Centre B11   (Sweden)

Author keywords

Ceramidase; Cystic fibrosis; Cystic fibrosis transmembrane conductanceregulator; Sphingomyelin; Sphingomyelinase.

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; NEUTRAL CERAMIDASE; PRIMER DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLON; CONTROLLED STUDY; CYSTIC FIBROSIS; DELETION MUTANT; ENZYME ACTIVITY; FEMALE; GENE DELETION; HETEROZYGOSITY; HOMOZYGOSITY; ISOTOPE LABELING; KIDNEY; LUNG; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE; SMALL INTESTINE MUCOSA; SPLEEN; TISSUE HOMOGENATE; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; C57BL MOUSE; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MICROVILLUS; MUTATION; ORGAN SIZE; WEIGHT REDUCTION;

MUS; MUS MUSCULUS;

ANIMALS; BODY WEIGHT; COLON; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA PRIMERS; FEMALE; HUMANS; INTESTINE, SMALL; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROVILLI; MUTATION; NEUTRAL CERAMIDASE; ORGAN SIZE; SEQUENCE DELETION; SPHINGOMYELIN PHOSPHODIESTERASE; WEIGHT LOSS;

EID: 59849088539     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181826daf     Document Type: Article

References (40)

1. Chalfant CE, Spiegel S. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci 2005; 118:4605-12.
2. Cuvillier O. Sphingosine in apoptosis signaling. Biochim Biophys Acta 2002;1585:153-62.
3. Gulbins E, Li PL. Physiological and pathophysiological aspects of ceramide. Am J Physiol Regul Integr Comp Physiol 2006; 290:R11-26.
4. Cuvillier O, Pirianov G, Kleuser B, et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996;381:800-3.
5. Boujaoude LC, Bradshaw-Wilder C, Mao C, et al. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate. J Biol Chem 2001;276: 35258-64.
6. Grassme H, Jendrossek V, Riehle A, et al. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 2003;9:322-30.
7. Zeidan Y, Ya H. Loss of acid sphingomyelinase induction by Pseudomonas aeruginosa in cystic fibrosis. 30th European Cystic Fibrosis Conference, Belek, Turkey, June 12-13, 2007.
8. Ito Y, Sato S, Ohashi T, et al. Reduction of airway anion secretion via CFTR in sphingomyelin pathway. Biochem Biophys Res Commun 2004;324:901-8.
9. Ramu Y, Xu Y, Lu Z. Inhibition of CFTR Cl- channel function caused by enzymatic hydrolysis of sphingomyelin. Proc Natl Acad Sci USA 2007;104:6448-53.
10. White NM, Corey DA, Kelley TJ. Mechanistic similarities between cultured cell models of cystic fibrosis and Niemann-pick type C. Am J Respir Cell Mol Biol 2004;31:538-43.
11. Lam RS, Shaw AR, Duszyk M. Membrane cholesterol content modulates activation of BK channels in colonic epithelia. Biochim Biophys Acta 2004;1667:241-8.
12. Duan RD, Nilsson A. Sphingolipid hydrolyzing enzymes in the gastrointestinal tract. Methods Enzymol 2000;311:276-86.
13. Nilsson A. The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. Biochim Biophys Acta 1969;176:339-47.
14. Wu J, Nilsson A, Jonsson BA, et al. Intestinal alkaline sphingo-myelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity. Biochem J 2006;394:299-308.
15. Amer MD, Hedlund E, Rochester J, et al. Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. Biol Neonate 2004;85:159-66.
16. Goggel R, Winoto-Morbach S, Vielhaber G, et al. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. Nat Med 2004;10:155-60.
17. Duan RD, Cheng Y, Jonsson BA, et al. Human meconium contains significant amounts of alkaline sphingomyelinase, neutral cerami-dase, and sphingolipid metabolites. Pediatr Res 2007;61:61-6.
18. Motouri M, Matsuyama H, Yamamura J, et al. Milk sphingomyelin accelerates enzymatic and morphological maturation of the intestine in artificially reared rats. J Pediatr Gastroenterol Nutr 2003;36:241-7.
19. Grubb BR. Ion transport across the normal and CF neonatal murine intestine. Am J Physiol 1999;277:G167-74.
20. Van Doorninck JH, French PJ, Verbeek E, et al. A mouse model for the cystic fibrosis delta F508 mutation. EMBO J 1995;14:4403-11.
21. French PJ, van Doorninck JH, Peters RH, et al. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. J Clin Invest 1996;98:1304-12.
22. Bijvelds MJ, Bronsveld I, Havinga R, et al. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events. Am J Physiol Gastrointest Liver Physiol 2005;288: G646-53.
23. Strong TV, Boehm K, Collins FS. Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. J Clin Invest 1994;93: 347-54.
24. Bronsveld I, Mekus F, Bijman J, et al. Residual chloride secretion in intestinal tissue of deltaF508 homozygous twins and siblings with cystic fibrosis. The European CF Twin and Sibling Study Consortium. Gastroenterology 2000;119:32-40.
25. Grubb BR, Gabriel SE. Intestinal physiology and pathology in gene-targeted mouse models of cystic fibrosis. Am J Physiol 1997;273 (2 Pt 1):G258-66.
26. Scholte BJ, Davidson DJ, Wilke M, et al. Animal models of cystic fibrosis. J Cyst Fibros 2004;3 (Suppl 2):183-90.
27. Olsson M, Duan RD, Ohlsson L, et al. Rat intestinal ceramidase: purification, properties, and physiological relevance. Am J Physiol Gastrointest Liver Physiol 2004;287:G929-37.
28. Ameen N, Alexis J, Salas P. Cellular localization of the cystic fibrosis transmembrane conductance regulator in mouse intestinal tract. Histochem Cell Biol 2000;114:69-75.
29. Wu J, Liu F, Nilsson A, et al. Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphin-gomyelinase activity. Am J Physiol Gastrointest Liver Physiol 2004;287:G967-73.
30. Ameen NA, van Donselaar E, Posthuma G, et al. Subcellular distribution of CFTR in rat intestine supports a physiologic role for CFTR regulation by vesicle traffic. Histochem Cell Biol 2000;114:219-28.
31. Van Biervliet S, Eggermont E, Marien P, et al. Combined impact of mucosal damage and of cystic fibrosis on the small intestinal brush border enzyme activities. Acta Clin Belg 2003;58:220-4.
32. Kobayashi T, Suzuki K. The glycosylceramidase in the murine intestine. Purification and substrate specificity. J Biol Chem 1981;256:7768-73.
33. Mailleau C, Paul A, Colin M, et al. Glycoconjugate metabolism in a cystic fibrosis knockout mouse model. Mol Genet Metab 2001;72:122-31.
34. Dragusin M, Wehner S, Kelly S, et al. Effects of sphingosine-1-phosphate and ceramide-1-phosphate on rat intestinal smooth muscle cells: implications for postoperative ileus. FASEB J 2006;20:1930-2.
35. Neglia JP, FitzSimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995;332:494-9.
36. Duan RD. Anticancer compounds and sphingolipid metabolism in the colon. In Vivo 2005;19:293-300.
37. Longo CA, Tyler D, Mallampalli RK. Sphingomyelin metabolism is developmentally regulated in rat lung. Am J Respir Cell Mol Biol 1997;16:605-12.
38. Legssyer R, Huaux F, Lebacq J, et al. Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice. Respir Res 2006;7:134.
39. Fukuda Y, Kihara A, Igarashi Y. Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1. Biochem Biophys Res Commun 2003;309:155-60.
40. Schwab SR, Cyster JG. Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol 2007;8 (12):1295-301.